Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verlinde

Showing results (41-50 of 252) with videos related to

Pageof 26
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|November 15, 2011
A validated Ultra High Pressure Liquid Chromatographic method for the characterisation of confiscated illegal slimming products containing anorexicsE Deconinck, K Verlinde, P Courselle, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosaLaurent Poirel, Laura Brinas, Annemie Verlinde, et al.
Acta Clinica Belgica|December 27, 2022
HOMA-IR and HOMA2-IR estimation based on glycated hemoglobin as an alternative for fasting glucoseJoris R Delanghe, Evelyn Verlinde, Marijn M Speeckaert, et al.
Parasitology|December 2, 2017
The calcium-dependent protein kinase 1 from Toxoplasma gondii as target for structure-based drug designEmily M Cardew, Christophe L M J Verlinde, Ehmke Pohl
Computers in Biology and Medicine|January 1, 1988
A microcomputer-based, R-wave triggered system for hemodynamic measurements in the forearmP C Chang, R Verlinde, T Bruning, et al.
Biochemistry|May 8, 1999
Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonistsW E Minke, C Roach, W G Hol, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2006
Reengineering CCA-adding enzymes to function as (U,G)- or dCdCdA-adding enzymes or poly(C,A) and poly(U,G) polymerasesHyundae D Cho, Christophe L M J Verlinde, Alan M Weiner
PDA Journal of Pharmaceutical Science and Technology|November 16, 2021
Is Retention Time and/or Structure Matching a Solution to the Challenge of Providing Quantitative Data When Screening for Extractables and Leachables by GC/MS?Dennis Jenke, Piet Christiaens, Philippe Verlinde, et al.
PDA Journal of Pharmaceutical Science and Technology|June 19, 2019
Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 1-Introduction to Errors in Chromatographic Screening for Organic Extractables and Leachables and Discussion of the Errors of OmissionPiet Christiaens, Jean-Marie Beusen, Philippe Verlinde, et al.
Current Opinion in Structural Biology|December 15, 2000
AB(5) toxins: structures and inhibitor designE Fan, E A Merritt, C L Verlinde, et al.
Pageof 26

Showing results (41-50 of 252) with videos related to

Sort By:
Pageof 26
Journal of Pharmaceutical and Biomedical Analysis|November 15, 2011
A validated Ultra High Pressure Liquid Chromatographic method for the characterisation of confiscated illegal slimming products containing anorexicsE Deconinck, K Verlinde, P Courselle, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosaLaurent Poirel, Laura Brinas, Annemie Verlinde, et al.
Acta Clinica Belgica|December 27, 2022
HOMA-IR and HOMA2-IR estimation based on glycated hemoglobin as an alternative for fasting glucoseJoris R Delanghe, Evelyn Verlinde, Marijn M Speeckaert, et al.
Parasitology|December 2, 2017
The calcium-dependent protein kinase 1 from Toxoplasma gondii as target for structure-based drug designEmily M Cardew, Christophe L M J Verlinde, Ehmke Pohl
Computers in Biology and Medicine|January 1, 1988
A microcomputer-based, R-wave triggered system for hemodynamic measurements in the forearmP C Chang, R Verlinde, T Bruning, et al.
Biochemistry|May 8, 1999
Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonistsW E Minke, C Roach, W G Hol, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 21, 2006
Reengineering CCA-adding enzymes to function as (U,G)- or dCdCdA-adding enzymes or poly(C,A) and poly(U,G) polymerasesHyundae D Cho, Christophe L M J Verlinde, Alan M Weiner
PDA Journal of Pharmaceutical Science and Technology|November 16, 2021
Is Retention Time and/or Structure Matching a Solution to the Challenge of Providing Quantitative Data When Screening for Extractables and Leachables by GC/MS?Dennis Jenke, Piet Christiaens, Philippe Verlinde, et al.
PDA Journal of Pharmaceutical Science and Technology|June 19, 2019
Identifying and Mitigating Errors in Screening for Organic Extractables and Leachables: Part 1-Introduction to Errors in Chromatographic Screening for Organic Extractables and Leachables and Discussion of the Errors of OmissionPiet Christiaens, Jean-Marie Beusen, Philippe Verlinde, et al.
Current Opinion in Structural Biology|December 15, 2000
AB(5) toxins: structures and inhibitor designE Fan, E A Merritt, C L Verlinde, et al.
Pageof 26